http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2677691-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3c7e0a96dc1d3d2c16f7ba909eb9b394
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-485
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-137
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-135
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-135
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-485
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-10
filingDate 2008-02-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_49959bdffdcda157c1588b3662dc5441
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b5556700fc032785d50854e78320ae5a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7d4e7fdaace09837d732f1c6ccff1df5
publicationDate 2008-08-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CA-2677691-A1
titleOfInvention Reducing side effects of tramadol
abstract The invention provides methods of reducing the side effects of tramadol. Accordingly, in one embodiment, the invention provides a method of reducing the incidence of newly-discovered side effects related to sexual function in human males taking a tramadol material. The method comprises administering a phosphodiesterase inhibitor to a male taking the tramadol material. The in vention also provides pharmaceutical compositions. In one embodiment, the co mposition comprises a tramadol material and a phosphodiesterase inhibitor. T he invention further provides kits. In one embodiment, the kit comprises a t ramadol material and a phosphodiesterase inhibitor.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8372414-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8202525-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8617577-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011087755-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011087755-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8741319-B2
priorityDate 2007-02-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID63013
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419505278
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448413499
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135413523
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419506374
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID33741
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5360515
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135398744
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419590271
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419506981
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419533818
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451844298
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID152743216
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135400189

Total number of triples: 46.